Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada

Clinical trial NCT02585401 · COMPLETED

Trial details

NCT number: NCT02585401
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Age-related Macular Degeneration (AMD)Central Retinal Vein Occlusion (CRVO)Diabetic Macular Edema (DME)

Start date: 2016-02-18
Primary completion: 2016-03-31
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.